Tim joined ARM as CEO in 2022 with more than 20 years of experience in the biotechnology industry. A company-builder with a focus on corporate culture, he has helped early-stage organizations create internal cohesion and advance strategic initiatives. As chief executive, Tim divides his time between managing ARM and its global staff of nearly 30 employees and serving as an external advocate on behalf of ARM’s membership and the broader cell and gene therapy sector. Tim received a B.A. in history and philosophy from Boston College and a J.D. from the Columbus School of Law at the Catholic University of America. He lives in Boston with his wife and children and is a passionate fan of the Boston Celtics.